Asset profile
Bevacizumab
Monoclonal antibody
Biosimilars tracked: Alymsys (bevacizumab-maly), BP-102, Jobevne (bevacizumab-nwgd), Vegzelma (bevacizumab-adcd), Zirabev (bevacizumab-bvzr), bevacizumab-awwb
Approvedregulatory verdict
Evidence outlook
Approved: Non-Small Cell Lung Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
82 competitors in this universe: 10 direct rivals (same mechanism and indication), 12 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Bevacizumab: this drug | Approved | Monoclonal antibody | VEGF-A, Vascular Endothelial Growth Factor Inhibitor | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| BAT1706 (Avzivi) | Approved | Monoclonal antibody | VEGF-A | ||
| Bevacizumab-Awwb (MVASI) | Approved | Monoclonal antibody | VEGF-A | ||
| Jobevne (bevacizumab-Nwgd) | Approved | Monoclonal antibody | VEGF-A | ||
| PF-06439535 | Approved | Monoclonal antibody | VEGF-A | ||
| Vegzelma (bevacizumab-Adcd) | Approved | Monoclonal antibody | VEGF-A | ||
| Zirabev (bevacizumab-Bvzr) | Approved | Monoclonal antibody | VEGF-A | ||
| HD204 | Phase 3 | Monoclonal antibody | VEGF-A | ||
| HLX04 | Phase 3 | Monoclonal antibody | VEGF-A | ||
| LY01008 | Phase 3 | Monoclonal antibody | VEGF-A | ||
| Aflibercept (Eylea) | Approved | Protein / enzyme therapeutic | VEGF-A, VEGF-A / VEGF-B / Placental Growth Factor (PlGF) | ||
| Brolucizumab-Dbll | Approved | Monoclonal antibody | VEGF-A | ||
| Pegaptanib (Macugen) | Approved | Small molecule | VEGF-A | ||
| Ranibizumab (Lucentis) | Approved | Monoclonal antibody | VEGF-A | ||
| ABBV-RGX-314 | Phase 3 | Gene therapy / editing | VEGF-A |
…and 67 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Compare head-to-head
vs BAT1706 · Non-Small Cell Lung Cancervs bevacizumab-awwb · Non-Small Cell Lung Cancervs PF-06439535 · Non-Small Cell Lung Cancervs HLX04 · Non-Small Cell Lung Cancervs LY01008 · Non-Small Cell Lung Cancervs Alymsys (bevacizumab-maly) · Non-Small Cell Lung Cancer
4 further head-to-head pairs are tracked; the rosters on each shared mechanism and indication page list every rival in the race.
Upcoming events
(464 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (73)
October 2026 (13)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-10-09 · NCT06447662 · CT.gov ↗
What to watch
Phase 2Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma …Active not recruiting
Est. primary completion 2026-10-21 · NCT03587311 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer, Metastatic Gastroesophageal Adenocarcinoma, DPD DeficiencyRecruiting
Est. primary completion 2026-10-22 · NCT06245356 · CT.gov ↗
What to watch
Phase 1Colorectal CancerActive not recruiting
Est. primary completion 2026-10-23 · NCT05464030 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Biliary Tract CancerActive not recruiting
Est. primary completion 2026-10-27 · NCT05775159 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-10-27 · NCT06789757 · CT.gov ↗
What to watch
Phase 2Metastatic Alveolar Soft Part Sarcoma, Unresectable Alveolar Soft Part SarcomaActive not recruiting
Est. primary completion 2026-10-31 · NCT03141684 · CT.gov ↗
What to watch
Phase 1/2Advanced/Metastatic Solid TumorsRecruiting
Est. primary completion 2026-10-31 · NCT05405595 · CT.gov ↗
What to watch
Phase 4Solid TumorRecruiting
Est. primary completion 2026-10-31 · NCT05525767 · CT.gov ↗
What to watch
Phase 2Colorectal Neoplasms MalignantRecruiting
Est. primary completion 2026-10-31 · NCT06643793 · CT.gov ↗
What to watch
Phase 2Gastric AdenocarcinomaActive not recruiting
Est. primary completion 2026-10-31 · NCT06667050 · CT.gov ↗
What to watch
Phase 1Metastatic Colorectal Cancer (CRC)Recruiting
Est. primary completion 2026-10-31 · NCT06825624 · CT.gov ↗
What to watch
Phase 2Advanced Ovarian CancerNot yet recruiting
Est. primary completion 2026-10-31 · NCT07120451 · CT.gov ↗
What to watch
November 2026 (11)
Phase 2GlioblastomaActive not recruiting
Est. primary completion 2026-11 · NCT03743662 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-11 · NCT04958811 · CT.gov ↗
What to watch
Early phase / not applicableRefractory Metastatic Colorectal CancerRecruiting
Est. primary completion 2026-11 · NCT05991102 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer, CRC, KRAS/NRAS MutationActive not recruiting
Est. primary completion 2026-11 · NCT06106308 · CT.gov ↗
What to watch
Phase 1/2Colorectal CancerNot yet recruiting
Est. primary completion 2026-11-01 · NCT06373133 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-11-01 · NCT06401824 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsActive not recruiting
Est. primary completion 2026-11-13 · NCT04626635 · CT.gov ↗
What to watch
Phase 2Gastric Cancer Adenocarcinoma MetastaticRecruiting
Est. primary completion 2026-11-13 · NCT06711471 · CT.gov ↗
What to watch
Phase 2Adebrelimab, Hepatocellular Carcinoma, Transformation, Bevacizumab, TACERecruiting
Est. primary completion 2026-11-15 · NCT05970666 · CT.gov ↗
What to watch
Phase 2ALK Gene Mutation, Lung Adenocarcinoma, ImmunotherapyRecruiting
Est. primary completion 2026-11-16 · NCT05266846 · CT.gov ↗
What to watch
Phase 2Recurrent Glioblastoma, Recurrent WHO Grade 4 GliomaRecruiting
Est. primary completion 2026-11-30 · NCT06160206 · CT.gov ↗
What to watch
December 2026 (49)
Phase 2RhabdomyosarcomaActive not recruiting
Est. primary completion 2026-12 · NCT01871766 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Carcinoma of Lung, TNM Stage 4Active not recruiting
Est. primary completion 2026-12 · NCT03786692 · CT.gov ↗
What to watch
Phase 3Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer …Recruiting
Est. primary completion 2026-12 · NCT05281471 · CT.gov ↗
What to watch
Phase 3Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma, Hepatocellular Carcinoma …Recruiting
Est. primary completion 2026-12 · NCT05482516 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT05654454 · CT.gov ↗
What to watch
Phase 2Unresectable Metastatic Colorectal CancerActive not recruiting
Est. primary completion 2026-12 · NCT06107413 · CT.gov ↗
What to watch
Phase 2Refractory Metastatic Colorectal CancerRecruiting
Est. primary completion 2026-12 · NCT06607458 · CT.gov ↗
What to watch
Phase 1/2Ovarian CancerRecruiting
Est. primary completion 2026-12 · NCT06840002 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT06844474 · CT.gov ↗
What to watch
Phase 2Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) …Not yet recruiting
Est. primary completion 2026-12 · NCT07233850 · CT.gov ↗
What to watch
Phase 2Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal MetastasisActive not recruiting
Est. primary completion 2026-12 · NCT07512674 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12-01 · NCT06683703 · CT.gov ↗
What to watch
Phase 2Overall Response RateRecruiting
Est. primary completion 2026-12-01 · NCT07090525 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2026-12-01 · NCT07192185 · CT.gov ↗
What to watch
Phase 2HER2-low Breast CancerRecruiting
Est. primary completion 2026-12-06 · NCT07446452 · CT.gov ↗
What to watch
Phase 1Advanced Malignant Solid TumorsActive not recruiting
Est. primary completion 2026-12-15 · NCT06571422 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C MutationActive not recruiting
Est. primary completion 2026-12-17 · NCT04185883 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerActive not recruiting
Est. primary completion 2026-12-24 · NCT05843188 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumourRecruiting
Est. primary completion 2026-12-24 · NCT06783647 · CT.gov ↗
What to watch
Phase 2Extensive-stage Small-cell Lung Cancer, Liver MetastasesRecruiting
Est. primary completion 2026-12-28 · NCT05588388 · CT.gov ↗
What to watch
Phase 3Colorectal Cancer Stage IVActive not recruiting
Est. primary completion 2026-12-30 · NCT05171660 · CT.gov ↗
What to watch
Phase 2HER-2 Negative Breast CancerRecruiting
Est. primary completion 2026-12-30 · NCT05398861 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-12-30 · NCT06031285 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerActive not recruiting
Est. primary completion 2026-12-30 · NCT06465563 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12-30 · NCT06982924 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer MetastaticNot yet recruiting
Est. primary completion 2026-12-30 · NCT07007767 · CT.gov ↗
What to watch
Phase 2Ovarian Cancer, Ovarian Carcinoma, Recurrent, Ovarian Cancer Metastatic Recurrent, Ovarian Cancer (OvCa)Recruiting
Est. primary completion 2026-12-30 · NCT07340164 · CT.gov ↗
What to watch
Phase 1Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage IV Renal Cell Cancer AJCC v7Active not recruiting
Est. primary completion 2026-12-31 · NCT02210117 · CT.gov ↗
What to watch
Phase 3CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT03148418 · CT.gov ↗
What to watch
Phase 3Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System NeoplasmsRecruiting
Est. primary completion 2026-12-31 · NCT03303495 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2026-12-31 · NCT03401294 · CT.gov ↗
What to watch
Phase 2Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2026-12-31 · NCT03937830 · CT.gov ↗
What to watch
Phase 1Solid Tumors or LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT05460767 · CT.gov ↗
What to watch
Phase 1Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT05488522 · CT.gov ↗
What to watch
Phase 1Ovarian CancerRecruiting
Est. primary completion 2026-12-31 · NCT05636111 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer MetastaticRecruiting
Est. primary completion 2026-12-31 · NCT05727163 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT05844046 · CT.gov ↗
What to watch
Phase 1Colon Cancer, Metastatic Colon CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT05848739 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2026-12-31 · NCT05867420 · CT.gov ↗
What to watch
Phase 1/2Glioma, Glioblastoma MultiformeRecruiting
Est. primary completion 2026-12-31 · NCT06011109 · CT.gov ↗
What to watch
Phase 2/3Colorectal Cancer, Liver MetastasesRecruiting
Est. primary completion 2026-12-31 · NCT06280495 · CT.gov ↗
What to watch
Early phase / not applicableRecurrent Ovarian CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06292286 · CT.gov ↗
What to watch
Phase 2Malignant AscitesRecruiting
Est. primary completion 2026-12-31 · NCT06433869 · CT.gov ↗
What to watch
Phase 3Glioblastoma Multiforme, Glioblastoma, Glioblastoma Multiforme, Adult, Glioma, Brain Tumor, Brain Tumor, Recurrent, Neoplasms, Neoplasms …Recruiting
Est. primary completion 2026-12-31 · NCT06496971 · CT.gov ↗
What to watch
Phase 1Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8 …Recruiting
Est. primary completion 2026-12-31 · NCT06696768 · CT.gov ↗
What to watch
Phase 2Colorectal Neoplasms, Secondary Malignant Neoplasm of LiverNot yet recruiting
Est. primary completion 2026-12-31 · NCT07007728 · CT.gov ↗
What to watch
Phase 2Advanced Breast CancerEnrolling by invitation
Est. primary completion 2026-12-31 · NCT07359404 · CT.gov ↗
What to watch
2027 (162)
January 2027 (8)
Phase 1Hematological Malignancy, Solid TumorRecruiting
Est. primary completion 2027-01 · NCT05828459 · CT.gov ↗
What to watch
Phase 2TNBC, Brain MetastasisRecruiting
Est. primary completion 2027-01 · NCT07623577 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-01-01 · NCT06971406 · CT.gov ↗
What to watch
Phase 2Hepato Cellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-01-01 · NCT07276100 · CT.gov ↗
What to watch
Phase 1/2Solid TumorRecruiting
Est. primary completion 2027-01-19 · NCT05584670 · CT.gov ↗
What to watch
Early phase / not applicableGlioblastoma, Radiotherapy, ChemotherapyRecruiting
Est. primary completion 2027-01-20 · NCT03144167 · CT.gov ↗
What to watch
Phase 2Unresectable Metastatic Rectal Cancer, CAPOX, Combination of RadioimmunotherapyNot yet recruiting
Est. primary completion 2027-01-30 · NCT07059949 · CT.gov ↗
What to watch
Phase 1Unresectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-01-31 · NCT05096715 · CT.gov ↗
What to watch
February 2027 (10)
Phase 2Unresectable Metastatic Colorectal Cancer, Microsatellite Stable (MSS) Colorectal Cancer (CRC), RAS-mutant Colorectal CancerNot yet recruiting
Est. primary completion 2027-02 · NCT06835179 · CT.gov ↗
What to watch
Phase 2Colorectal CancerNot yet recruiting
Est. primary completion 2027-02 · NCT07229846 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-02-01 · NCT05440708 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer Liver MetastasisRecruiting
Est. primary completion 2027-02-01 · NCT06801665 · CT.gov ↗
What to watch
Phase 2Malignant Neoplasms of Female Genital Organs, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal CancerActive not recruiting
Est. primary completion 2027-02-02 · NCT02884648 · CT.gov ↗
What to watch
Phase 1Epithelial Ovarian, Fallopian Tube, Primary Peritoneal CancerActive not recruiting
Est. primary completion 2027-02-02 · NCT05053750 · CT.gov ↗
What to watch
Phase 1Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma, Metastatic Hepatocellular Carcinoma …Active not recruiting
Est. primary completion 2027-02-02 · NCT05075993 · CT.gov ↗
What to watch
Phase 2Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)Active not recruiting
Est. primary completion 2027-02-10 · NCT06271837 · CT.gov ↗
What to watch
Phase 2Liver MetastasesRecruiting
Est. primary completion 2027-02-28 · NCT05062317 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02-28 · NCT06047379 · CT.gov ↗
What to watch
March 2027 (11)
Phase 1/2Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic, Optic Nerve Glioma, Pleomorphic Xanthoastrocytoma …Active not recruiting
Est. primary completion 2027-03 · NCT01837862 · CT.gov ↗
What to watch
Phase 2/3Colorectal NeoplasmsActive not recruiting
Est. primary completion 2027-03 · NCT05141721 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-03 · NCT05516628 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Liver Neoplasms, Carcinoma, HepatocellularRecruiting
Est. primary completion 2027-03 · NCT07246668 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-03-10 · NCT06860490 · CT.gov ↗
What to watch
Phase 2Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma …Recruiting
Est. primary completion 2027-03-15 · NCT05231122 · CT.gov ↗
What to watch
Phase 4Carcinoma, Ovarian EpithelialActive not recruiting
Est. primary completion 2027-03-15 · NCT06121401 · CT.gov ↗
What to watch
Early phase / not applicableProliferative Diabetic Retinopathy - High RiskRecruiting
Est. primary completion 2027-03-20 · NCT06899529 · CT.gov ↗
What to watch
Phase 1Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma …Active not recruiting
Est. primary completion 2027-03-25 · NCT04227028 · CT.gov ↗
What to watch
Phase 2Unresectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-03-31 · NCT06360042 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-03-31 · NCT06427941 · CT.gov ↗
What to watch
April 2027 (13)
Phase 3Ovarian Cancer, Peritoneal Cancer, Fallopian Tube CancerActive not recruiting
Est. primary completion 2027-04 · NCT05445778 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-04 · NCT07453394 · CT.gov ↗
What to watch
Phase 2HCC - Hepatocellular Carcinoma, Conversion TherapyRecruiting
Est. primary completion 2027-04 · NCT07560488 · CT.gov ↗
What to watch
Phase 3Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant, GBM, Brain Cancer, Glioblastoma, IDH-wildtype, Glioblastoma Multiforme, AdultRecruiting
Est. primary completion 2027-04-01 · NCT05271240 · CT.gov ↗
What to watch
Phase 1/2Cancer, Colorectal Cancer, Solid Tumor, Locally Advanced Solid Tumor, Metastatic Cancer, WNT Pathway, HCC, Desmoid …Recruiting
Est. primary completion 2027-04-01 · NCT05919264 · CT.gov ↗
What to watch
Phase 1Acute LeukemiaNot yet recruiting
Est. primary completion 2027-04-01 · NCT06876701 · CT.gov ↗
What to watch
Phase 1/2Advanced Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-04-01 · NCT06995105 · CT.gov ↗
What to watch
Early phase / not applicableAdvanced Hepatocellular Carcinoma, Chemotherapy, Stereotactic Body RadiotherapyRecruiting
Est. primary completion 2027-04-25 · NCT06595108 · CT.gov ↗
What to watch
Phase 4Hepatocellular Carcinoma, Hepatocellular CancerRecruiting
Est. primary completion 2027-04-30 · NCT05185505 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma Non-resectableRecruiting
Est. primary completion 2027-04-30 · NCT06397222 · CT.gov ↗
What to watch
Phase 2Hepato Cellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-04-30 · NCT06742424 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-04-30 · NCT06799065 · CT.gov ↗
What to watch
Phase 2Endometrial Adenocarcinoma, Endometrial CancerRecruiting
Est. primary completion 2027-04-30 · NCT06917092 · CT.gov ↗
What to watch
May 2027 (11)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-05 · NCT03896074 · CT.gov ↗
What to watch
Phase 2Advanced Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-05 · NCT06986785 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-05 · NCT07014215 · CT.gov ↗
What to watch
Phase 2Cervical Cancer, Endometrial CancerRecruiting
Est. primary completion 2027-05 · NCT07054567 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-05-01 · NCT06411600 · CT.gov ↗
What to watch
Phase 1Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2027-05-01 · NCT06882915 · CT.gov ↗
What to watch
Phase 2Colo-rectal Cancer, MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersRecruiting
Est. primary completion 2027-05-01 · NCT07003022 · CT.gov ↗
What to watch
Phase 2Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal CarcinomaRecruiting
Est. primary completion 2027-05-17 · NCT06420973 · CT.gov ↗
What to watch
Phase 2Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2027-05-31 · NCT04721132 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumors, Colorectal CancerRecruiting
Est. primary completion 2027-05-31 · NCT06004245 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-05-31 · NCT07559760 · CT.gov ↗
What to watch
June 2027 (19)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT04999761 · CT.gov ↗
What to watch
Phase 2Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal CarcinomaRecruiting
Est. primary completion 2027-06 · NCT05200260 · CT.gov ↗
What to watch
Phase 1/2Pancreatic CancerRecruiting
Est. primary completion 2027-06 · NCT06427239 · CT.gov ↗
What to watch
Phase 2Lung CancerNot yet recruiting
Est. primary completion 2027-06 · NCT07244926 · CT.gov ↗
What to watch
Phase 1/2Colorectal CancerRecruiting
Est. primary completion 2027-06 · NCT07653685 · CT.gov ↗
What to watch
Phase 3Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7Active not recruiting
Est. primary completion 2027-06-01 · NCT02997228 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-06-01 · NCT06557096 · CT.gov ↗
What to watch
Phase 1Solid TumorRecruiting
Est. primary completion 2027-06-01 · NCT06576037 · CT.gov ↗
What to watch
Phase 3Ovarian Clear Cell CarcinomaRecruiting
Est. primary completion 2027-06-01 · NCT07002346 · CT.gov ↗
What to watch
Phase 2Extensive Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-06-01 · NCT07083375 · CT.gov ↗
What to watch
Phase 1/2Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma …Active not recruiting
Est. primary completion 2027-06-16 · NCT05627635 · CT.gov ↗
What to watch
Phase 1/2Tumours, GynecologicalRecruiting
Est. primary completion 2027-06-21 · NCT06796907 · CT.gov ↗
What to watch
Phase 2/3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT03178552 · CT.gov ↗
What to watch
Phase 3NeoplasmsActive not recruiting
Est. primary completion 2027-06-30 · NCT05112965 · CT.gov ↗
What to watch
Phase 1/2Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal CancerRecruiting
Est. primary completion 2027-06-30 · NCT05739981 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-06-30 · NCT06792695 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06-30 · NCT06953843 · CT.gov ↗
What to watch
Phase 2BRAF V600 Colorectal CancerRecruiting
Est. primary completion 2027-06-30 · NCT07150247 · CT.gov ↗
What to watch
Phase 1/2Solid TumorNot yet recruiting
Est. primary completion 2027-06-30 · NCT07612137 · CT.gov ↗
What to watch
July 2027 (18)
Phase 3Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-07 · NCT04803994 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-07 · NCT05005403 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-07 · NCT05579366 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer Liver MetastasisRecruiting
Est. primary completion 2027-07 · NCT06590259 · CT.gov ↗
What to watch
Phase 1Advanced Colorectal Cancer, Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-07 · NCT06867822 · CT.gov ↗
What to watch
Phase 2pMMR/MSS Locally Advanced Rectal CancerRecruiting
Est. primary completion 2027-07-01 · NCT07005570 · CT.gov ↗
What to watch
Early phase / not applicableLocally Advanced Rectal Cancer (LARC), 5-12cm to Anal VergeNot yet recruiting
Est. primary completion 2027-07-01 · NCT07769853 · CT.gov ↗
What to watch
Phase 1Solid TumorsActive not recruiting
Est. primary completion 2027-07-27 · NCT05238922 · CT.gov ↗
What to watch
Phase 1/2Advanced Liver CancersActive not recruiting
Est. primary completion 2027-07-30 · NCT04524871 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2027-07-30 · NCT06096779 · CT.gov ↗
What to watch
Phase 2Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2027-07-31 · NCT03181100 · CT.gov ↗
What to watch
Phase 2Respiratory Tract Diseases, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Neoplasms, Squamous Cell …Active not recruiting
Est. primary completion 2027-07-31 · NCT05797246 · CT.gov ↗
What to watch
Phase 3Hepatocellular Carcinoma Non-resectableRecruiting
Est. primary completion 2027-07-31 · NCT05985798 · CT.gov ↗
What to watch
Phase 2Gastric Cancer (GC)Not yet recruiting
Est. primary completion 2027-07-31 · NCT07045805 · CT.gov ↗
What to watch
Phase 2Advanced Colorectal CancerRecruiting
Est. primary completion 2027-07-31 · NCT07106034 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC), Second Line TreatmentActive not recruiting
Est. primary completion 2027-07-31 · NCT07138885 · CT.gov ↗
What to watch
Phase 1/2Resectable Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2027-07-31 · NCT07714317 · CT.gov ↗
What to watch
August 2027 (11)
Phase 1Sarcoma, Desmoplastic Small Round Cell Tumor (DSRCT)Active not recruiting
Est. primary completion 2027-08 · NCT01189643 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-08 · NCT06695026 · CT.gov ↗
What to watch
Phase 1/2Cervical CancerRecruiting
Est. primary completion 2027-08 · NCT07080216 · CT.gov ↗
What to watch
Phase 2Peritoneal Malignant MesotheliomaRecruiting
Est. primary completion 2027-08-01 · NCT05001880 · CT.gov ↗
What to watch
Phase 4Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-08-01 · NCT07059494 · CT.gov ↗
What to watch
Phase 2Colo-rectal Cancer, Third-line and Beyond Therapy, TAS 102, BevacizumabRecruiting
Est. primary completion 2027-08-01 · NCT07085169 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-08-01 · NCT07733050 · CT.gov ↗
What to watch
Phase 2Ras-mutated Metastatic Colorectal Cancer, mCRC, MSS Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-08-30 · NCT07446322 · CT.gov ↗
What to watch
Phase 3Venous ThrombosisActive not recruiting
Est. primary completion 2027-08-31 · NCT04649489 · CT.gov ↗
What to watch
Phase 2Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Vulvar Cancer, Vagina Neoplasm, Clear Cell CarcinomaRecruiting
Est. primary completion 2027-08-31 · NCT06023862 · CT.gov ↗
What to watch
Phase 2mCRCNot yet recruiting
Est. primary completion 2027-08-31 · NCT07116577 · CT.gov ↗
What to watch
September 2027 (18)
Phase 2Cancer, Tumors, Neoplasm, NeoplasiaRecruiting
Est. primary completion 2027-09 · NCT02925234 · CT.gov ↗
What to watch
Phase 1Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers, Esophageal Squamous Cell Carcinoma …Recruiting
Est. primary completion 2027-09 · NCT06084481 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2027-09 · NCT06679985 · CT.gov ↗
What to watch
Phase 2Adhesive CapsulitisRecruiting
Est. primary completion 2027-09 · NCT06976671 · CT.gov ↗
What to watch
Phase 2Breast Cancer With Brain Metastasis, HER2-low Expressing Breast CancerRecruiting
Est. primary completion 2027-09 · NCT07150208 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2027-09-01 · NCT05976568 · CT.gov ↗
What to watch
Phase 3Cervical CancerRecruiting
Est. primary completion 2027-09-01 · NCT06459687 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer Liver MetastasisRecruiting
Est. primary completion 2027-09-01 · NCT06788171 · CT.gov ↗
What to watch
Phase 2Colorectal CancerNot yet recruiting
Est. primary completion 2027-09-01 · NCT07123441 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2027-09-01 · NCT07774247 · CT.gov ↗
What to watch
Phase 2Triple-negative Breast CancerRecruiting
Est. primary completion 2027-09-10 · NCT05192798 · CT.gov ↗
What to watch
Phase 1Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-09-23 · NCT04837716 · CT.gov ↗
What to watch
Phase 1CarcinomaActive not recruiting
Est. primary completion 2027-09-27 · NCT01061515 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorRecruiting
Est. primary completion 2027-09-28 · NCT06233942 · CT.gov ↗
What to watch
Phase 2Appendix Adenocarcinoma, Human Papillomavirus-Related Anal Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2027-09-30 · NCT03074513 · CT.gov ↗
What to watch
Early phase / not applicableRecurrent GlioblastomaRecruiting
Est. primary completion 2027-09-30 · NCT05284643 · CT.gov ↗
What to watch
Phase 2Ovarian CancerRecruiting
Est. primary completion 2027-09-30 · NCT06083844 · CT.gov ↗
What to watch
Phase 2Colorectal CancerRecruiting
Est. primary completion 2027-09-30 · NCT07474727 · CT.gov ↗
What to watch
October 2027 (7)
Phase 2/3Rectal CancerNot yet recruiting
Est. primary completion 2027-10 · NCT07134218 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-10 · NCT07134413 · CT.gov ↗
What to watch
Phase 1Advanced Unresectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-10 · NCT07478302 · CT.gov ↗
What to watch
Phase 2Cervical CancerNot yet recruiting
Est. primary completion 2027-10 · NCT07497074 · CT.gov ↗
What to watch
Phase 2Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Urothelial Cancer …Recruiting
Est. primary completion 2027-10-01 · NCT05489211 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma, Rectal Cancer, Metastatic …Recruiting
Est. primary completion 2027-10-20 · NCT07407465 · CT.gov ↗
What to watch
Phase 1Colorectal CancerActive not recruiting
Est. primary completion 2027-10-31 · NCT06547385 · CT.gov ↗
What to watch
November 2027 (4)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-11 · NCT05029882 · CT.gov ↗
What to watch
Phase 2Resectable Hepatocellular Carcinoma With High Risk of RecurrenceRecruiting
Est. primary completion 2027-11-10 · NCT07239245 · CT.gov ↗
What to watch
Phase 1Dynamic Tumor Resistance, Metastatic Colorectal CancerNot yet recruiting
Est. primary completion 2027-11-14 · NCT07318389 · CT.gov ↗
What to watch
Phase 1Solid Tumor, AdultRecruiting
Est. primary completion 2027-11-30 · NCT06265688 · CT.gov ↗
What to watch
December 2027 (32)
Phase 3Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration …Active not recruiting
Est. primary completion 2027-12 · NCT05112861 · CT.gov ↗
What to watch
Phase 1/2Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC), Colorectal CancerRecruiting
Est. primary completion 2027-12 · NCT05482893 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-12 · NCT07179900 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2027-12 · NCT07522411 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Biliary Tract CancerRecruiting
Est. primary completion 2027-12-01 · NCT05733598 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal Cancer (LARC)Recruiting
Est. primary completion 2027-12-01 · NCT07347951 · CT.gov ↗
What to watch
Phase 2GlioblastomaRecruiting
Est. primary completion 2027-12-01 · NCT07670026 · CT.gov ↗
What to watch
Phase 2/3Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma …Active not recruiting
Est. primary completion 2027-12-15 · NCT05063552 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma(HCC)Recruiting
Est. primary completion 2027-12-15 · NCT06893887 · CT.gov ↗
What to watch
Phase 1/2Ovarian CancerRecruiting
Est. primary completion 2027-12-25 · NCT07042802 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumourRecruiting
Est. primary completion 2027-12-26 · NCT07111546 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12-30 · NCT06663306 · CT.gov ↗
What to watch
Phase 2HCCNot yet recruiting
Est. primary completion 2027-12-30 · NCT07119931 · CT.gov ↗
What to watch
Phase 2Lung CancerNot yet recruiting
Est. primary completion 2027-12-30 · NCT07197008 · CT.gov ↗
What to watch
Phase 2Ovarian Cancer Metastatic, Ovarian Cancer Metastatic RecurrentRecruiting
Est. primary completion 2027-12-30 · NCT07311577 · CT.gov ↗
What to watch
Phase 2Platinum-resistant Recurrent Ovarian Cancer (PROC)Not yet recruiting
Est. primary completion 2027-12-30 · NCT07314619 · CT.gov ↗
What to watch
Phase 2Hepatecellular Carcinoma, RALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin, Bevacizumab …Recruiting
Est. primary completion 2027-12-30 · NCT07327788 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Active not recruiting
Est. primary completion 2027-12-30 · NCT07380633 · CT.gov ↗
What to watch
Early phase / not applicableNon-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12-30 · NCT07398599 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-12-30 · NCT07503756 · CT.gov ↗
What to watch
Early phase / not applicableESCCRecruiting
Est. primary completion 2027-12-30 · NCT07627347 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-12-31 · NCT04449874 · CT.gov ↗
What to watch
Phase 2Hereditary Leiomyomatosis and Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma …Recruiting
Est. primary completion 2027-12-31 · NCT04981509 · CT.gov ↗
What to watch
Phase 1Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT06478693 · CT.gov ↗
What to watch
Phase 1Unresectable Colorectal CancerActive not recruiting
Est. primary completion 2027-12-31 · NCT06540261 · CT.gov ↗
What to watch
Phase 2Locally Advanced Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT06752382 · CT.gov ↗
What to watch
Phase 2Lung AdenocarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07416058 · CT.gov ↗
What to watch
Phase 2Advanced Gynecological MalignanciesRecruiting
Est. primary completion 2027-12-31 · NCT07448922 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2027-12-31 · NCT07490262 · CT.gov ↗
What to watch
Phase 2ctDNA, Chemotherapy, Colorectal CancerRecruiting
Est. primary completion 2027-12-31 · NCT07562490 · CT.gov ↗
What to watch
Phase 1/2Unresectable Advanced or Metastatic Colorectal CancerNot yet recruiting
Est. primary completion 2027-12-31 · NCT07750041 · CT.gov ↗
What to watch
2028 (129)
January 2028 (9)
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2028-01 · NCT06563986 · CT.gov ↗
What to watch
Phase 2Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer (PSOC)Recruiting
Est. primary completion 2028-01 · NCT07024784 · CT.gov ↗
What to watch
Phase 1/2Solid CancerActive not recruiting
Est. primary completion 2028-01-01 · NCT06771622 · CT.gov ↗
What to watch
Phase 2Dyspnea Caused by 2019-nCoVNot yet recruiting
Est. primary completion 2028-01-01 · NCT07089719 · CT.gov ↗
What to watch
Phase 2/3Cerebral AV MalformationRecruiting
Est. primary completion 2028-01-15 · NCT06264531 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-01-30 · NCT06294548 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC), Immunotherapy, PD-1, CTLA-4, TACENot yet recruiting
Est. primary completion 2028-01-30 · NCT07128251 · CT.gov ↗
What to watch
Phase 2mCRC, HER2, Targeted Therapy, Antibody-drug ConjugatesNot yet recruiting
Est. primary completion 2028-01-30 · NCT07355764 · CT.gov ↗
What to watch
Phase 2Kidney CancerActive not recruiting
Est. primary completion 2028-01-31 · NCT01217931 · CT.gov ↗
What to watch
February 2028 (11)
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2028-02 · NCT04727307 · CT.gov ↗
What to watch
Phase 2Colo-rectal CancerNot yet recruiting
Est. primary completion 2028-02 · NCT07178717 · CT.gov ↗
What to watch
Phase 1PROC, Platinum Resistant Ovarian Cancer, Endometrial CancerRecruiting
Est. primary completion 2028-02 · NCT07470853 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-02-01 · NCT06728865 · CT.gov ↗
What to watch
Phase 2Patients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line TreatmentNot yet recruiting
Est. primary completion 2028-02-01 · NCT07337551 · CT.gov ↗
What to watch
Phase 2Colorectal CancerRecruiting
Est. primary completion 2028-02-15 · NCT06948448 · CT.gov ↗
What to watch
Phase 1/2Advanced Cholangiocarcinoma, FGFR2 FusionRecruiting
Est. primary completion 2028-02-22 · NCT06439485 · CT.gov ↗
What to watch
Phase 1Colorectal Neoplasms, Gastrointestinal NeoplasmsRecruiting
Est. primary completion 2028-02-25 · NCT06663319 · CT.gov ↗
What to watch
Phase 2Ovarian CancerActive not recruiting
Est. primary completion 2028-02-28 · NCT04931342 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer With Left-sided Primary Tumor, ImmunotherapyNot yet recruiting
Est. primary completion 2028-02-28 · NCT07070713 · CT.gov ↗
What to watch
March 2028 (11)
Phase 2Immunotherapy, HCC - Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-03 · NCT05690048 · CT.gov ↗
What to watch
Phase 2Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-typeRecruiting
Est. primary completion 2028-03 · NCT05742425 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2028-03 · NCT06820463 · CT.gov ↗
What to watch
Phase 1Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Pancreatic CancerRecruiting
Est. primary completion 2028-03 · NCT07066657 · CT.gov ↗
What to watch
Phase 3Unresectable Metastatic Colorectal CancerRecruiting
Est. primary completion 2028-03-04 · NCT06642844 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-03-27 · NCT05528952 · CT.gov ↗
What to watch
Phase 2Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)Recruiting
Est. primary completion 2028-03-27 · NCT07518602 · CT.gov ↗
What to watch
Phase 1Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Melanoma …Recruiting
Est. primary completion 2028-03-30 · NCT05039801 · CT.gov ↗
What to watch
Phase 2Glioblastoma, Recurrence TumorRecruiting
Est. primary completion 2028-03-30 · NCT07263438 · CT.gov ↗
What to watch
Phase 2Ovarian Cancer, Platinum Sensitive Ovarian Cancer (PSOC)Not yet recruiting
Est. primary completion 2028-03-30 · NCT07776171 · CT.gov ↗
What to watch
Early phase / not applicableBiliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-03-31 · NCT07466238 · CT.gov ↗
What to watch
April 2028 (12)
Phase 1/2Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC), ImmunotherapyRecruiting
Est. primary completion 2028-04 · NCT07244705 · CT.gov ↗
What to watch
Phase 1/2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-04 · NCT07479485 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-04 · NCT07551778 · CT.gov ↗
What to watch
Phase 3Colorectal CancerRecruiting
Est. primary completion 2028-04-01 · NCT06733038 · CT.gov ↗
What to watch
Phase 2Gastric Cancer (GC), AFP Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-04-01 · NCT07515625 · CT.gov ↗
What to watch
Early phase / not applicableCorneal NeovascularisationRecruiting
Est. primary completion 2028-04-01 · NCT07642960 · CT.gov ↗
What to watch
Phase 1Colorectal Cancer MetastaticRecruiting
Est. primary completion 2028-04-15 · NCT07193862 · CT.gov ↗
What to watch
Early phase / not applicableHCCActive not recruiting
Est. primary completion 2028-04-28 · NCT07009470 · CT.gov ↗
What to watch
Phase 2Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma …Recruiting
Est. primary completion 2028-04-30 · NCT04919629 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-04-30 · NCT06839105 · CT.gov ↗
What to watch
Phase 1/2Colorectal Cancer, Metastatic Colorectal Cancer With RAS MutationEnrolling by invitation
Est. primary completion 2028-04-30 · NCT06936527 · CT.gov ↗
What to watch
Phase 2Ovarian Cancer, Recurrent Ovarian CancerRecruiting
Est. primary completion 2028-04-30 · NCT07714668 · CT.gov ↗
What to watch
May 2028 (3)
Early phase / not applicableMulti-organ Metastatic Colorectal CancerActive not recruiting
Est. primary completion 2028-05 · NCT01792934 · CT.gov ↗
What to watch
Phase 1/2Solid TumorsRecruiting
Est. primary completion 2028-05-31 · NCT05101070 · CT.gov ↗
What to watch
Phase 3Colorectal CancerRecruiting
Est. primary completion 2028-05-31 · NCT06497985 · CT.gov ↗
What to watch
June 2028 (10)
Phase 1/2Chronic Subdural HematomaRecruiting
Est. primary completion 2028-06 · NCT06510582 · CT.gov ↗
What to watch
Phase 2Colorectal NeoplasmsNot yet recruiting
Est. primary completion 2028-06-01 · NCT07535632 · CT.gov ↗
What to watch
Phase 2Ovarian CancerRecruiting
Est. primary completion 2028-06-18 · NCT06971744 · CT.gov ↗
What to watch
Phase 2BRAF V600 Wild Type, Clinical Stage IV Cutaneous Melanoma AJCC v8, Intracranial Melanoma, Metastatic Malignant Neoplasm in the Brain …Active not recruiting
Est. primary completion 2028-06-30 · NCT03175432 · CT.gov ↗
What to watch
Phase 1Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal CancerRecruiting
Est. primary completion 2028-06-30 · NCT04516447 · CT.gov ↗
What to watch
Phase 2Advanced Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2028-06-30 · NCT06737913 · CT.gov ↗
What to watch
Phase 2Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal CancerRecruiting
Est. primary completion 2028-06-30 · NCT06787612 · CT.gov ↗
What to watch
Phase 1/2Malignant AscitesRecruiting
Est. primary completion 2028-06-30 · NCT07397819 · CT.gov ↗
What to watch
Phase 2TNBC, Triple Negative Breast Cancer, Brain MetastasasesRecruiting
Est. primary completion 2028-06-30 · NCT07638852 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsNot yet recruiting
Est. primary completion 2028-06-30 · NCT07774611 · CT.gov ↗
What to watch
July 2028 (12)
Phase 4Oncology, Infusion ReactionRecruiting
Est. primary completion 2028-07 · NCT06031233 · CT.gov ↗
What to watch
Phase 2Colorectal CancerActive not recruiting
Est. primary completion 2028-07 · NCT06268015 · CT.gov ↗
What to watch
Phase 2Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress SyndromeRecruiting
Est. primary completion 2028-07 · NCT06701656 · CT.gov ↗
What to watch
Phase 2Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress SyndromeRecruiting
Est. primary completion 2028-07 · NCT06703073 · CT.gov ↗
What to watch
Phase 3Radiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases, Radiation Toxicity, Radiation Effect, Radiation Injury …Recruiting
Est. primary completion 2028-07 · NCT06888817 · CT.gov ↗
What to watch
Phase 3Metastatic Colorectal CancerNot yet recruiting
Est. primary completion 2028-07 · NCT07025239 · CT.gov ↗
What to watch
Phase 3Advanced Endometrial Carcinoma, Recurrent Endometrial CarcinomaRecruiting
Est. primary completion 2028-07-01 · NCT07198074 · CT.gov ↗
What to watch
Phase 4Biliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-07-01 · NCT07619235 · CT.gov ↗
What to watch
Phase 3CancerActive not recruiting
Est. primary completion 2028-07-05 · NCT03768063 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Portal Vein Tumor Thrombus, Oligometastases, Radiotherapy, Immunotherapy, Hepatic Artery Infusion ChemotherapyRecruiting
Est. primary completion 2028-07-25 · NCT07062055 · CT.gov ↗
What to watch
Phase 1Colonrectal Cancer (CRC)Not yet recruiting
Est. primary completion 2028-07-31 · NCT07656038 · CT.gov ↗
What to watch
Phase 2Colorectal Neoplasms Malignant, Neoplasm, MetastaticRecruiting
Est. primary completion 2028-07-31 · NCT07722754 · CT.gov ↗
What to watch
August 2028 (10)
Phase 3Radionecrosis of Brain, Brain MetastasesRecruiting
Est. primary completion 2028-08 · NCT06471465 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid Tumor Cancer, Triple-Negative Breast Cancer (TNBC), CNS Disease, Breast CancerNot yet recruiting
Est. primary completion 2028-08 · NCT07681297 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor ThrombusRecruiting
Est. primary completion 2028-08-01 · NCT05984511 · CT.gov ↗
What to watch
Phase 2Ovary CancerRecruiting
Est. primary completion 2028-08-01 · NCT06540729 · CT.gov ↗
What to watch
Phase 1/2Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell CarcinomaRecruiting
Est. primary completion 2028-08-04 · NCT05797168 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-08-15 · NCT07420439 · CT.gov ↗
What to watch
Phase 2Lung Neoplasms, Pulmonary Neoplasms, Lymph Node Involvement, Pulmonary NoduleNot yet recruiting
Est. primary completion 2028-08-17 · NCT06809946 · CT.gov ↗
What to watch
Early phase / not applicableGlioma, Recurrent Glioma, Recurrent GlioblastomaRecruiting
Est. primary completion 2028-08-31 · NCT07074756 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer (Diagnosis)Not yet recruiting
Est. primary completion 2028-08-31 · NCT07134101 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma, Atezolizumab Plus Bevacizumab, Transarterial ChemoembolizationNot yet recruiting
Est. primary completion 2028-08-31 · NCT07543510 · CT.gov ↗
What to watch
September 2028 (11)
Phase 3Colorectal NeoplasmsRecruiting
Est. primary completion 2028-09 · NCT02885753 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2028-09 · NCT05854498 · CT.gov ↗
What to watch
Phase 2/3Cervical CancerEnrolling by invitation
Est. primary completion 2028-09 · NCT06755515 · CT.gov ↗
What to watch
Phase 1/2Advan'ce'd, AdvancedNot yet recruiting
Est. primary completion 2028-09 · NCT07361991 · CT.gov ↗
What to watch
Phase 1/2Ovarian CancerNot yet recruiting
Est. primary completion 2028-09 · NCT07637851 · CT.gov ↗
What to watch
Early phase / not applicableMalignant Pleural Effusions (Mpe)Not yet recruiting
Est. primary completion 2028-09-01 · NCT07670338 · CT.gov ↗
What to watch
Phase 2TNBC - Triple-Negative Breast CancerRecruiting
Est. primary completion 2028-09-25 · NCT07351487 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma Non-resectableRecruiting
Est. primary completion 2028-09-30 · NCT06133062 · CT.gov ↗
What to watch
Phase 1/2Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC, Gastrointestinal Cancer, Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09-30 · NCT06445062 · CT.gov ↗
What to watch
Phase 2ORR,OS,PFSNot yet recruiting
Est. primary completion 2028-09-30 · NCT07328802 · CT.gov ↗
What to watch
Phase 3Breast Cancer, Triple Negative Breast Cancer (TNBC)Not yet recruiting
Est. primary completion 2028-09-30 · NCT07669610 · CT.gov ↗
What to watch
October 2028 (5)
Phase 1/2Glioblastoma Multiforme, Anaplastic AstrocytomaRecruiting
Est. primary completion 2028-10 · NCT01269853 · CT.gov ↗
What to watch
Phase 3Ovarian Cancer, Platinum-sensitive Ovarian Cancer, PSOCRecruiting
Est. primary completion 2028-10 · NCT07225270 · CT.gov ↗
What to watch
Phase 2Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2028-10-08 · NCT07288034 · CT.gov ↗
What to watch
Phase 3Colorectal CancerRecruiting
Est. primary completion 2028-10-31 · NCT07722494 · CT.gov ↗
What to watch
November 2028 (5)
Phase 1Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors, HER2-positive Metastatic Breast Cancer …Recruiting
Est. primary completion 2028-11 · NCT06625775 · CT.gov ↗
What to watch
Phase 3Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Neoplasm MetastasisRecruiting
Est. primary completion 2028-11 · NCT07213804 · CT.gov ↗
What to watch
Phase 3Ovarian CancerRecruiting
Est. primary completion 2028-11-01 · NCT06819007 · CT.gov ↗
What to watch
Phase 1Brain Arteriovenous MalformationsNot yet recruiting
Est. primary completion 2028-11-01 · NCT07075757 · CT.gov ↗
What to watch
Phase 2Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical SiteNot yet recruiting
Est. primary completion 2028-11-30 · NCT07547592 · CT.gov ↗
What to watch
December 2028 (30)
Phase 2Pancreatic CancerActive not recruiting
Est. primary completion 2028-12 · NCT03351296 · CT.gov ↗
What to watch
Phase 1Ewing Sarcoma, Colorectal AdenocarcinomaRecruiting
Est. primary completion 2028-12 · NCT03715933 · CT.gov ↗
What to watch
Phase 1/2GlioblastomaActive not recruiting
Est. primary completion 2028-12 · NCT04121455 · CT.gov ↗
What to watch
Phase 3Ovarian Cancer, Fallopian Tube Cancer, Peritoneal CancerRecruiting
Est. primary completion 2028-12 · NCT05009082 · CT.gov ↗
What to watch
Phase 3Hepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2028-12 · NCT06680258 · CT.gov ↗
What to watch
Early phase / not applicableUterine Cervical NeoplasmNot yet recruiting
Est. primary completion 2028-12 · NCT06878196 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumorsRecruiting
Est. primary completion 2028-12 · NCT06895928 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerNot yet recruiting
Est. primary completion 2028-12 · NCT07071844 · CT.gov ↗
What to watch
Phase 1Ovarian CancerRecruiting
Est. primary completion 2028-12 · NCT07278336 · CT.gov ↗
What to watch
Phase 2Acral Melanoma, Mucosal MelanomaNot yet recruiting
Est. primary completion 2028-12 · NCT07347444 · CT.gov ↗
What to watch
Phase 2Advanced Microsatellite Stable Colorectal CancerRecruiting
Est. primary completion 2028-12 · NCT07527858 · CT.gov ↗
What to watch
Phase 1Advanced HBV-Related Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-12 · NCT07557251 · CT.gov ↗
What to watch
Phase 1/2Advanced Colorectal CancerNot yet recruiting
Est. primary completion 2028-12 · NCT07737600 · CT.gov ↗
What to watch
Early phase / not applicableGBMNot yet recruiting
Est. primary completion 2028-12-01 · NCT07274787 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2028-12-01 · NCT07331883 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2028-12-05 · NCT07317414 · CT.gov ↗
What to watch
Phase 3CRC (Colorectal Cancer)Recruiting
Est. primary completion 2028-12-29 · NCT07284849 · CT.gov ↗
What to watch
Phase 2Metastatic Breast CancerRecruiting
Est. primary completion 2028-12-30 · NCT05769010 · CT.gov ↗
What to watch
Phase 2Lung Cancer, Inoperable DiseaseRecruiting
Est. primary completion 2028-12-30 · NCT06483347 · CT.gov ↗
What to watch
Phase 2Hepatic Cancer, SurgeryRecruiting
Est. primary completion 2028-12-30 · NCT06492408 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12-30 · NCT06492421 · CT.gov ↗
What to watch
Phase 3Multiple Brain Metastases in Lung AdenocarcinomaRecruiting
Est. primary completion 2028-12-30 · NCT07058428 · CT.gov ↗
What to watch
Phase 3Colorectal Cancer Metastatic, Microsatellite Stable (MSS) Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2028-12-30 · NCT07729605 · CT.gov ↗
What to watch
Phase 2Rectal CancerActive not recruiting
Est. primary completion 2028-12-31 · NCT04017455 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaEnrolling by invitation
Est. primary completion 2028-12-31 · NCT05441475 · CT.gov ↗
What to watch
Phase 4PD-(L)1, CTLA-4, Advanced Melanoma, Iparomlimab, Tuvonralimab, BevacizumabNot yet recruiting
Est. primary completion 2028-12-31 · NCT07004335 · CT.gov ↗
What to watch
Phase 2Cervical Cancer Stage IVA, Cervical Cancer MetastaticNot yet recruiting
Est. primary completion 2028-12-31 · NCT07035808 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma, Transarterial ChemoembolizationNot yet recruiting
Est. primary completion 2028-12-31 · NCT07281664 · CT.gov ↗
What to watch
Phase 1/2Metastatic Colorectal Cancer (mCRC)Not yet recruiting
Est. primary completion 2028-12-31 · NCT07391566 · CT.gov ↗
What to watch
Phase 2Glioma, AdultRecruiting
Est. primary completion 2028-12-31 · NCT07678684 · CT.gov ↗
What to watch
2029 (51)
January 2029 (4)
Phase 2Ovarian CancerRecruiting
Est. primary completion 2029-01 · NCT07059845 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Neoadjuvant Therapy, Sintilimab, BevacizimabRecruiting
Est. primary completion 2029-01 · NCT07324824 · CT.gov ↗
What to watch
Phase 1Chronic Subdural HematomaNot yet recruiting
Est. primary completion 2029-01-01 · NCT07729098 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2029-01-04 · NCT06697197 · CT.gov ↗
What to watch
February 2029 (3)
Phase 3Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2029-02-01 · NCT04712643 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2029-02-01 · NCT07395063 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-02-28 · NCT07472647 · CT.gov ↗
What to watch
March 2029 (5)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-03-06 · NCT07661173 · CT.gov ↗
What to watch
Phase 3Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8Recruiting
Est. primary completion 2029-03-10 · NCT07166406 · CT.gov ↗
What to watch
Phase 1/2Ovarian Cancer RecurrentRecruiting
Est. primary completion 2029-03-27 · NCT06843447 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2029-03-30 · NCT06339424 · CT.gov ↗
What to watch
Phase 2Carcinoma, HepatocellularRecruiting
Est. primary completion 2029-03-31 · NCT07010497 · CT.gov ↗
What to watch
April 2029 (6)
Phase 2MesotheliomaNot yet recruiting
Est. primary completion 2029-04 · NCT07514793 · CT.gov ↗
What to watch
Phase 2Ovarian CancersNot yet recruiting
Est. primary completion 2029-04 · NCT07663513 · CT.gov ↗
What to watch
Phase 2Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma …Recruiting
Est. primary completion 2029-04-12 · NCT07504588 · CT.gov ↗
What to watch
Phase 1Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Colorectal Cancer, Metastatic Colorectal Adenocarcinoma …Recruiting
Est. primary completion 2029-04-14 · NCT07318805 · CT.gov ↗
What to watch
Phase 3Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal CancerRecruiting
Est. primary completion 2029-04-27 · NCT06824467 · CT.gov ↗
What to watch
Phase 3Rectal Adenocarcinoma, High-Risk Cancer, MSSRecruiting
Est. primary completion 2029-04-30 · NCT07549399 · CT.gov ↗
What to watch
May 2029 (2)
June 2029 (8)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-06 · NCT06400472 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2029-06-01 · NCT07621497 · CT.gov ↗
What to watch
Phase 1Glioma, Glioblastoma, Recurrent Glioma, Recurrent Glioblastoma, Grade 4 Malignant Glioma of Brain (Disorder)Recruiting
Est. primary completion 2029-06-11 · NCT07541781 · CT.gov ↗
What to watch
Phase 2Short-course Radiotherapy Plus Chemotherapy …Recruiting
Est. primary completion 2029-06-24 · NCT07674732 · CT.gov ↗
What to watch
Phase 3Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma …Recruiting
Est. primary completion 2029-06-30 · NCT04181060 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2029-06-30 · NCT06605664 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorRecruiting
Est. primary completion 2029-06-30 · NCT06953323 · CT.gov ↗
What to watch
Phase 2CRC (Colorectal Cancer)Recruiting
Est. primary completion 2029-06-30 · NCT07728019 · CT.gov ↗
What to watch
July 2029 (2)
Phase 3Non-Resectable Pancreas CarcinomaRecruiting
Est. primary completion 2029-07-01 · NCT07235930 · CT.gov ↗
What to watch
Phase 2Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV), Papillomavirus Infection, Laryngeal Diseases, Tracheal Diseases …Not yet recruiting
Est. primary completion 2029-07-01 · NCT07756840 · CT.gov ↗
What to watch
August 2029 (2)
September 2029 (7)
Phase 3Metastatic Colorectal CancerActive not recruiting
Est. primary completion 2029-09 · NCT04188145 · CT.gov ↗
What to watch
Phase 2Recurrent Triple-Negative Breast CancerRecruiting
Est. primary completion 2029-09 · NCT06976944 · CT.gov ↗
What to watch
Phase 3Advanced Colorectal CancerRecruiting
Est. primary completion 2029-09 · NCT07676162 · CT.gov ↗
What to watch
Phase 3Ovarian NeoplasmsNot yet recruiting
Est. primary completion 2029-09-06 · NCT07694427 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-09-12 · NCT06131840 · CT.gov ↗
What to watch
Phase 3Lung Adenocarcinoma, Brain Metastases, Radiotherapy, Intensity-Modulated, Bevacizumab, Whole-Brain RadiotherapyRecruiting
Est. primary completion 2029-09-15 · NCT07481786 · CT.gov ↗
What to watch
Phase 1/2HCC - Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2029-09-30 · NCT07761286 · CT.gov ↗
What to watch
October 2029 (3)
Phase 2Metastatic Colorectal CancerActive not recruiting
Est. primary completion 2029-10 · NCT04587128 · CT.gov ↗
What to watch
Phase 1/2Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas, Oligodendroglioma, Diffuse Intrinsic Brainstem Glioma …Recruiting
Est. primary completion 2029-10-01 · NCT05956821 · CT.gov ↗
What to watch
Phase 3Metastatic Colorectal CancerRecruiting
Est. primary completion 2029-10-16 · NCT07549412 · CT.gov ↗
What to watch
November 2029 (1)
Phase 2/3Metastatic Colorectal CancerRecruiting
Est. primary completion 2029-11 · NCT05462613 · CT.gov ↗
What to watch
December 2029 (8)
Phase 3Platinum-Sensitive Ovarian Cancer, Ovarian CancerRecruiting
Est. primary completion 2029-12 · NCT07564141 · CT.gov ↗
What to watch
Phase 2Neurofibromatosis Type 2, Vestibular Schwannoma, Non-vestibular Schwannoma, Meningioma, EpendymomaRecruiting
Est. primary completion 2029-12-01 · NCT04374305 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-12-30 · NCT07182708 · CT.gov ↗
What to watch
Phase 2Lung Cancer Stage IIIRecruiting
Est. primary completion 2029-12-31 · NCT03872661 · CT.gov ↗
What to watch
Phase 2GlioblastomaActive not recruiting
Est. primary completion 2029-12-31 · NCT06061809 · CT.gov ↗
What to watch
Phase 2Ovarian CancerNot yet recruiting
Est. primary completion 2029-12-31 · NCT07370818 · CT.gov ↗
What to watch
Phase 2Rectal Neoplasms MalignantNot yet recruiting
Est. primary completion 2029-12-31 · NCT07383285 · CT.gov ↗
What to watch
2030 (27)
January 2030 (1)
Phase 2Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic TreatmentRecruiting
Est. primary completion 2030-01-01 · NCT06254248 · CT.gov ↗
What to watch
February 2030 (3)
Phase 2Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, NeoadjuvantRecruiting
Est. primary completion 2030-02 · NCT06890338 · CT.gov ↗
What to watch
Phase 2/3Untreated, Unresectable, or Metastatic Colorectal CancerRecruiting
Est. primary completion 2030-02-02 · NCT07221357 · CT.gov ↗
What to watch
Phase 3Ovarian CancerNot yet recruiting
Est. primary completion 2030-02-28 · NCT07779538 · CT.gov ↗
What to watch
March 2030 (4)
Phase 2/3Hepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2030-03-01 · NCT07392866 · CT.gov ↗
What to watch
Phase 2Locally Recurrent Rectal CancerRecruiting
Est. primary completion 2030-03-09 · NCT07183865 · CT.gov ↗
What to watch
Phase 2Locally Recurrent Rectal CancerRecruiting
Est. primary completion 2030-03-10 · NCT06928584 · CT.gov ↗
What to watch
Phase 3Hepatocellular CarcinomaRecruiting
Est. primary completion 2030-03-15 · NCT06921785 · CT.gov ↗
What to watch
April 2030 (3)
Phase 2Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor RecurrentRecruiting
Est. primary completion 2030-04 · NCT01356290 · CT.gov ↗
What to watch
Phase 3Colorectal Cancer, Chemotherapy EffectRecruiting
Est. primary completion 2030-04-01 · NCT05797467 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorsRecruiting
Est. primary completion 2030-04-30 · NCT05719558 · CT.gov ↗
What to watch
May 2030 (6)
Phase 4Cervical CancerRecruiting
Est. primary completion 2030-05 · NCT07645625 · CT.gov ↗
What to watch
Phase 3Ovarian CancerRecruiting
Est. primary completion 2030-05-01 · NCT06954584 · CT.gov ↗
What to watch
Phase 3Ovarian NeoplasmsRecruiting
Est. primary completion 2030-05-21 · NCT07684612 · CT.gov ↗
What to watch
Phase 1Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube CancerRecruiting
Est. primary completion 2030-05-27 · NCT06469281 · CT.gov ↗
What to watch
Phase 3Hepatocellular CarcinomaRecruiting
Est. primary completion 2030-05-30 · NCT07594340 · CT.gov ↗
What to watch
Phase 1/2Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8 …Recruiting
Est. primary completion 2030-05-31 · NCT03942328 · CT.gov ↗
What to watch
June 2030 (1)
Phase 1/2Ovarian CancerNot yet recruiting
Est. primary completion 2030-06-01 · NCT06990516 · CT.gov ↗
What to watch
August 2030 (1)
Phase 1Metastatic Colorectal CancerRecruiting
Est. primary completion 2030-08-31 · NCT04929223 · CT.gov ↗
What to watch
September 2030 (1)
Phase 1/2Metastatic Breast CancerRecruiting
Est. primary completion 2030-09-30 · NCT03424005 · CT.gov ↗
What to watch
December 2030 (7)
Phase 1/2Advanced Renal Cell CarcinomaRecruiting
Est. primary completion 2030-12 · NCT07239596 · CT.gov ↗
What to watch
Phase 1Phase 1, SAR445877, FOlfox6, Bevacizimab, First Line Treatment, Metastatic Colorectal Cancer (CRC), Microsatellite StableRecruiting
Est. primary completion 2030-12-27 · NCT07500298 · CT.gov ↗
What to watch
Phase 2Liver Cancer, AntibodyRecruiting
Est. primary completion 2030-12-30 · NCT06482801 · CT.gov ↗
What to watch
Phase 3Colorectal Cancer (CRC), pMMR/MSS Adenocarcinoma of the Colon or RectumRecruiting
Est. primary completion 2030-12-31 · NCT06791512 · CT.gov ↗
What to watch
Phase 2/3Immune Checkpoint Therapy, Radiotherapy, Metastatic Colorectal Cancer (CRC)Recruiting
Est. primary completion 2030-12-31 · NCT06958419 · CT.gov ↗
What to watch
Phase 2Colorectal Liver Metastasis (CRLM)Recruiting
Est. primary completion 2030-12-31 · NCT06988852 · CT.gov ↗
What to watch
Phase 1/2Relapsed NeuroblastomaRecruiting
Est. primary completion 2030-12-31 · NCT07334301 · CT.gov ↗
What to watch
2031 (12)
January 2031 (1)
Phase 1/2Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma …Recruiting
Est. primary completion 2031-01-31 · NCT06543576 · CT.gov ↗
What to watch
February 2031 (3)
Phase 3Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum …Recruiting
Est. primary completion 2031-02-28 · NCT07271355 · CT.gov ↗
What to watch
Phase 2/3Metastatic Colorectal Cancer (CRC), Liposomal Irinotecan, Second-LineNot yet recruiting
Est. primary completion 2031-02-28 · NCT07585279 · CT.gov ↗
What to watch
Phase 2Ovarian CancerNot yet recruiting
Est. primary completion 2031-02-28 · NCT07647653 · CT.gov ↗
What to watch
March 2031 (1)
Phase 1/2Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma RecurrentRecruiting
Est. primary completion 2031-03-31 · NCT07346157 · CT.gov ↗
What to watch
April 2031 (1)
Phase 3Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2031-04 · NCT07691762 · CT.gov ↗
What to watch
June 2031 (2)
Phase 1/2Hepatocellular Carcinoma (HCC), Macrovascular Invasion, Liver Transplant Surgery, DownstagingRecruiting
Est. primary completion 2031-06 · NCT06725121 · CT.gov ↗
What to watch
Phase 2Resectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2031-06 · NCT07018947 · CT.gov ↗
What to watch
August 2031 (1)
Phase 3Ovarian Cancer, Peritoneal Cancer, Fallopian Tube CancerNot yet recruiting
Est. primary completion 2031-08-31 · NCT07743164 · CT.gov ↗
What to watch
October 2031 (2)
December 2031 (1)
Phase 2Ovarian CancerNot yet recruiting
Est. primary completion 2031-12-01 · NCT07720180 · CT.gov ↗
What to watch
2032 (3)
March 2032 (1)
Phase 3Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer, Fallopian Tube CancerRecruiting
Est. primary completion 2032-03-19 · NCT07776691 · CT.gov ↗
What to watch
May 2032 (1)
Phase 3Ovarian CancerNot yet recruiting
Est. primary completion 2032-05-01 · NCT07797283 · CT.gov ↗
What to watch
June 2032 (1)
Phase 1/2Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor, Pediatric Cancer, Pediatric Solid Tumor, Fibrolamellar CarcinomaRecruiting
Est. primary completion 2032-06 · NCT05468359 · CT.gov ↗
What to watch
2033 (3)
February 2033 (1)
Phase 3Ovarian Neoplasms, Ovarian CancerRecruiting
Est. primary completion 2033-02-25 · NCT07318558 · CT.gov ↗
What to watch
March 2033 (1)
June 2033 (1)
Phase 2/3Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal CancerRecruiting
Est. primary completion 2033-06-30 · NCT07472140 · CT.gov ↗
What to watch
2034 (2)
March 2034 (1)
Phase 2/3Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2034-03-31 · NCT07293468 · CT.gov ↗
What to watch
December 2034 (1)
Phase 3Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma …Recruiting
Est. primary completion 2034-12-31 · NCT06580314 · CT.gov ↗
What to watch
2040 (1)
July 2040 (1)
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2040-07-01 · NCT05620771 · CT.gov ↗
What to watch
2043 (1)
July 2043 (1)
Phase 2Colorectal NeoplasmsActive not recruiting
Est. primary completion 2043-07 · NCT02487992 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.